老年心肌梗死后预防药物治疗的时间趋势。
Time trends in preventive drug treatment after myocardial infarction in older patients.
机构信息
Leiden University Medical Center, Department of Public Health and Primary Care, Leiden, The Netherlands.
出版信息
Br J Gen Pract. 2010 Jan;60(570):47-9. doi: 10.3399/bjgp10X482103.
Abstract
Secondary preventive drug treatment in patients aged > or =60 years with a history of myocardial infarction was investigated for age-dependent differences in time trends. Sixteen general practices in the Netherlands participated. Preventive treatment with at least three of four drugs (antithrombotics, statins, beta-blockers, and/or angiotensin-converting enzyme inhibitors) increased significantly over time in all three age strata of older patients. Although the greatest relative increase (2.2 times greater) took place in patients aged > or =80 years, these patients consistently had most room for improvement.
摘要
研究了年龄依赖性心肌梗死后病史 > 或 =60 岁患者的二级预防药物治疗的时间趋势差异。荷兰的 16 家全科诊所参与了此项研究。在所有三个老年患者年龄组中，随着时间的推移，至少使用四种药物（抗血栓药、他汀类药物、β受体阻滞剂和/或血管紧张素转换酶抑制剂）的预防性治疗显著增加。虽然年龄 > 或 =80 岁的患者的相对增加幅度最大（增加了 2.2 倍），但这些患者仍有很大的改善空间。
相似文献
1
Time trends in preventive drug treatment after myocardial infarction in older patients.老年心肌梗死后预防药物治疗的时间趋势。
Br J Gen Pract. 2010 Jan;60(570):47-9. doi: 10.3399/bjgp10X482103.
2
Long-term secondary prevention of acute myocardial infarction (SEPAT) - guidelines adherence and outcome.急性心肌梗死的长期二级预防（SEPAT）——指南依从性与结局
BMC Cardiovasc Disord. 2016 Nov 17;16(1):226. doi: 10.1186/s12872-016-0400-6.
3
Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.急性心肌梗死后二级预防药物的起始使用及长期依从性
BMC Cardiovasc Disord. 2016 May 31;16:115. doi: 10.1186/s12872-016-0283-6.
4
Association of Secondary Preventive Cardiovascular Treatment After Myocardial Infarction With Mortality Among Patients With Schizophrenia.心肌梗死后二级预防心血管治疗与精神分裂症患者死亡率的关系。
JAMA Psychiatry. 2018 Dec 1;75(12):1234-1240. doi: 10.1001/jamapsychiatry.2018.2742.
5
Underuse of cardioprotective medications in patients prior to acute myocardial infarction.急性心肌梗死患者在发病前心脏保护药物使用不足。
Am J Cardiol. 2003 Jul 15;92(2):209-11. doi: 10.1016/s0002-9149(03)00541-1.
6
Chronic polytherapy after myocardial infarction: the trade-off between hospital and community-based providers in determining adherence to medication.心肌梗死后的慢性多疗法治疗：医院和社区提供者在确定药物依从性方面的权衡。
BMC Cardiovasc Disord. 2021 Apr 14;21(1):180. doi: 10.1186/s12872-021-01969-9.
7
Prevalence and correlates of non-optimal secondary medical prevention in patients with stable coronary artery disease.稳定型冠状动脉疾病患者非最佳二级医疗预防的患病率及其相关因素
Arch Cardiovasc Dis. 2015 Jun-Jul;108(6-7):340-6. doi: 10.1016/j.acvd.2015.01.007. Epub 2015 Apr 6.
8
Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.急性心肌梗死存活患者出院时循证医学疗法使用情况的十年趋势（2001年至2011年）
Am J Cardiol. 2016 Dec 15;118(12):1792-1797. doi: 10.1016/j.amjcard.2016.08.065. Epub 2016 Sep 13.
9
Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction.设计和/或实施随机试验的医生与从事常规临床实践的医生在急性心肌梗死药物治疗使用方面的趋势：MILIS-TIMI研究经验。梗死面积限制多中心调查。心肌梗死溶栓治疗。
Am Heart J. 1999 Jan;137(1):79-92. doi: 10.1016/s0002-8703(99)70462-x.
10
Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.心肌梗死后二级预防治疗的纵向持续性与患者风险的关系。
Heart. 2015 May 15;101(10):800-7. doi: 10.1136/heartjnl-2014-306754. Epub 2015 Mar 23.
引用本文的文献
1
Initiation of anti-osteoporosis medication following hip fracture in older adults: a systematic review and thematic synthesis of qualitative studies from patient and healthcare professional perspectives.老年人髋部骨折后抗骨质疏松药物的使用：一项基于患者和医护人员视角的定性研究的系统评价与主题综合分析
Age Ageing. 2025 Aug 1;54(8). doi: 10.1093/ageing/afaf237.
2
Prescribing and medical non-adherence after myocardial infarction: qualitative interviews with general practitioners in Germany.心肌梗死后的处方和医疗不依从：德国全科医生的定性访谈。
BMC Fam Pract. 2020 May 8;21(1):81. doi: 10.1186/s12875-020-01145-6.
3
Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.1999年至2013年间二级预防中他汀类药物使用情况及心血管事件复发率的时间趋势：一项基于注册登记的研究
BMC Cardiovasc Disord. 2018 Nov 6;18(1):209. doi: 10.1186/s12872-018-0941-y.
4
Drug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter?老年二级心血管预防中的药物处方率：心血管疾病病史的脆弱性和严重程度有影响吗？
Scand J Prim Health Care. 2015;33(4):260-8. doi: 10.3109/02813432.2015.1117281.
5
GPs' perspectives on secondary cardiovascular prevention in older age: a focus group study in the Netherlands.全科医生对老年人二级心血管预防的看法：荷兰的一项焦点小组研究
Br J Gen Pract. 2015 Nov;65(640):e739-47. doi: 10.3399/bjgp15X687373.
6
Age- and gender-related differences in drug utilisation and adverse drug reaction patterns among patients in a coronary care unit.冠心病监护病房患者药物使用及药物不良反应模式的年龄和性别差异
Singapore Med J. 2014 Apr;55(4):221-8. doi: 10.11622/smedj.2014056.
7
NT-proBNP best predictor of cardiovascular events and cardiovascular mortality in secondary prevention in very old age: the Leiden 85-plus Study.NT-proBNP 是高龄老年患者二级预防中心血管事件和心血管死亡率的最佳预测因子：莱顿 85 岁以上研究。
PLoS One. 2013 Nov 21;8(11):e81400. doi: 10.1371/journal.pone.0081400. eCollection 2013.
8
GPs' perspectives on preventive care for older people: a focus group study.全科医生对老年人预防保健的看法：一项焦点小组研究。
Br J Gen Pract. 2012 Nov;62(604):e765-72. doi: 10.3399/bjgp12X658296.
9
Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional study.英国西米德兰兹地区年龄和性别对心血管疾病一级预防治疗的影响：横断面研究。
BMJ. 2012 Jul 12;345:e4535. doi: 10.1136/bmj.e4535.
本文引用的文献
1
Trends in secondary prevention of ischaemic heart disease in the UK 1994 2005: use of individual and combination treatment.1994 - 2005年英国缺血性心脏病二级预防的趋势：个体治疗与联合治疗的应用情况
Heart. 2008 Jan;94(1):83-8. doi: 10.1136/hrt.2006.111757. Epub 2007 May 31.
2
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.美国心脏协会/美国心脏病学会关于冠心病和其他动脉粥样硬化性血管疾病患者二级预防的指南：2006年更新版：得到美国国立心肺血液研究所认可。
Circulation. 2006 May 16;113(19):2363-72. doi: 10.1161/CIRCULATIONAHA.106.174516.
3
Epidemiology, clinical features, and prognosis of acute myocardial infarction in the elderly.老年人急性心肌梗死的流行病学、临床特征及预后
Am J Geriatr Cardiol. 2006 Jan-Feb;15(1):7-11; quiz 12. doi: 10.1111/j.1076-7460.2006.05273.x.
4
Secondary prevention of coronary heart disease in older patients after the national service framework: population based study.国家服务框架实施后老年患者冠心病的二级预防：基于人群的研究
BMJ. 2006 Jan 21;332(7534):144-5. doi: 10.1136/bmj.38704.770127.BE. Epub 2006 Jan 9.
5
Evidence for inequalities in the management of coronary heart disease in Scotland.苏格兰冠心病管理方面存在不平等现象的证据。
Heart. 2005 May;91(5):630-4. doi: 10.1136/hrt.2004.036723.
6
Two decades of progress in preventing vascular disease.预防血管疾病二十年的进展。
Lancet. 2002 Jul 6;360(9326):2-3. doi: 10.1016/S0140-6736(02)09358-3.
Zotero 插件